Corcept Therapeutics (CORT) Times Interest Earned (2010 - 2017)

Corcept Therapeutics has disclosed Times Interest Earned across 8 years of filings, most recently posting $130.56 for Q2 2017.

• Times Interest Earned for Q2 2017 came in at $130.56, up 4497.35% year-over-year; the trailing twelve-month figure through Mar 2018 was $705.2 (up 8036.4% YoY), and the FY2016 annual result was $4.99, up 529.91% from the prior year.
• Times Interest Earned came in at $130.56 for Q2 2017 at Corcept Therapeutics, up from $21.07 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $130.56 in Q2 2017 to a low of -$12.01 in Q1 2014.
• The 5-year median for Times Interest Earned is -$2.64 (2014), against an average of $5.83.
• Across the five-year window, Times Interest Earned slipped 25.19% in 2014 and soared 4497.35% in 2017, its largest moves.
• Corcept Therapeutics' Times Interest Earned stood at -$9.17 in 2013, then surged by 58.97% to -$3.76 in 2014, then jumped by 163.43% to $2.39 in 2015, then soared by 411.86% to $12.21 in 2016, then surged by 969.11% to $130.56 in 2017.
• The last three Times Interest Earned figures came in at $130.56 (Q2 2017), $21.07 (Q1 2017), and $12.21 (Q4 2016), per Business Quant data.